NCT00171093View on ClinicalTrials.gov

A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia

PHASE3CompletedINTERVENTIONAL
Enrollment

369

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

January 31, 2006

Conditions
HYPERTENSIONHYPERCHOLESTEROLEMIA
Interventions
DRUG

valsartan + simvastatin

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00171093 - A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia | Biotech Hunter | Biotech Hunter